Rosa Marina Melillo

Prof. Rosa Marina Melillo

Department of Molecular Medicine and Medical Biotecnology, University of Naples Federico II, Naples, Italy
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1990 in Cell
Verified
Journal Article
Closed access
MGMichele Grieco
Michele Grieco
MSMassimo Santoro
Massimo Santoro
MBMaria Teresa Berlingieri
Maria Teresa Berlingieri
Rosa Marina MelilloRosa Marina Melillo
Rosa Marina Melillo
RDRosangela Donghi
Rosangela Donghi
GVGiancarlo Vecchiot
Giancarlo Vecchiot

16 September 2002 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
GVGiuseppe Viglietto
Giuseppe Viglietto
MMMaria Letizia Motti
Maria Letizia Motti
PBPaola Bruni
Paola Bruni
Rosa Marina MelilloRosa Marina Melillo
Rosa Marina Melillo
ADAmelia D'Alessio
Amelia D'Alessio
MSMassimo Santoro
Massimo Santoro

10 March 2005 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
Rosa Marina MelilloRosa Marina Melillo
Rosa Marina Melillo
Maria Domenica CastelloneMaria Domenica Castellone
Maria Domenica Castellone
VGValentina Guarino
Valentina Guarino
Valentina De FalcoValentina De Falco
Valentina De Falco
ACAnna Maria Cirafici
Anna Maria Cirafici
MSMassimo Mattia SANTORO
Massimo Mattia SANTORO
In papillary thyroid carcinomas (PTCs), rearrangements of the RET receptor (RET/PTC) and activating mutations in the BRAF or RAS oncogenes are mutually exclusive. Here we show that the 3 proteins function along a linear oncogenic signaling cascade in which RET/PTC induces RAS-dependent BRAF activation and RAS- and BRAF-dependent ERK activation. Adoptive activation of the RET/PTC-RAS-BRAF axis induced cell proliferation and Matrigel invasion of thyroid follicular cells. Gene expression profiling revealed that the 3 oncogenes activate a common transcriptional program in thyroid cells that includes upregulation of the CXCL1 and CXCL10 chemokines, which in turn stimulate proliferation and invasion. Thus, motile and mitogenic properties are intrinsic to transformed thyroid cells and are governed by an epistatic oncogenic signaling cascade.

1 June 2006 in Cancer Cell
Verified
Journal Article
Closed access
Monica FedeleMonica Fedele
Monica Fedele
Rosa VisoneRosa Visone
Rosa Visone
IMIvana De Martino
Ivana De Martino
GTGiancarlo Troncone
Giancarlo Troncone
DPDario Palmieri
Dario Palmieri
Alfredo FuscoAlfredo Fusco
Alfredo Fusco

23 August 2010 in Oncogene
Verified
Journal Article
Closed access
Rosa Marina MelilloRosa Marina Melillo
Rosa Marina Melillo
VGV Guarino
V Guarino
EAE Avilla
E Avilla
MGMaria Rosaria Galdiero
Maria Rosaria Galdiero
FLFederica Liotti
Federica Liotti
GMG Marone
G Marone

26 January 2015 in Oncogene
Verified
Journal Article
Closed access
CVC Visciano
C Visciano
FLFederica Liotti
Federica Liotti
NPN Prevete
N Prevete
GCG Cali'
G Cali'
RFRenato Franco
Renato Franco
Rosa Marina MelilloRosa Marina Melillo
Rosa Marina Melillo